Impact of Parental Perfectionistic Cognitions Self-compassion Intervention Effects on Shame in Child Health Context
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03504605|
Recruitment Status : Completed
First Posted : April 20, 2018
Last Update Posted : July 26, 2019
|Condition or disease||Intervention/treatment||Phase|
|Diabetes Mellitus, Type 1 Epilepsy Asthma Shame Self-Compassion Stress Perfectionistic Cognitions||Other: Online self-compassion intervention||Not Applicable|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||344 participants|
|Intervention Model:||Parallel Assignment|
|Primary Purpose:||Supportive Care|
|Official Title:||The Role of Parental Perfectionistic Cognitions in an Intervention to Improve Self- Compassion and Reduce Shame: Findings in the Context of Child Chronic Health Conditions|
|Actual Study Start Date :||August 15, 2018|
|Actual Primary Completion Date :||January 23, 2019|
|Actual Study Completion Date :||July 25, 2019|
Experimental: Self-compassion intervention
Participants will be asked to recall and write (in an online text-box) about a parenting event during which they felt shame. They will then receive the online self-compassion intervention as detailed in Sirois, Bögels and Emerson (in revision). This involves parents in the experimental condition being given a validated set of instructions asking them to reflect on the event and write self-compassionate responses (see intervention).
Other: Online self-compassion intervention
Parents are asked to write in an online text box about a parenting event in which they felt shame. They are then given a validated set of instructions asking them to reflect on the event and write self-compassionate responses.
No Intervention: Control
Participants will be asked to recall and write (in an online text-box) about a parenting event during which they felt shame. Those in the control condition will be asked to re-read the account of the event and make notes about factual information (e.g. time of day, who was there, etc.). It should be noted that if the SCI is found to reduce state shame and increase state self-compassion, it will be offered to participants in the control group.
- Self-compassion Scale [ Time Frame: Change from baseline trait self-compassion through to study completion (anticipated one week). ]Outcome measure to assess trait self-compassion, which is defined as a trait in which people are mindful to emotions and respond towards themself with kindness and with a sense of common humanity, through difficulties, or following perceived failure/ personal shortcomings
- PANAS-X [ Time Frame: Change from baseline shame through to study completion (anticipated one week). ]Outcome measure to assess shame, defined as a self-conscious emotion, distinct from guilt as it is constructed of negative evaluation directed towards the self (as opposed to behaviours).
- Self-compassion items [ Time Frame: Change from baseline state self-compassion through to study completion (anticipated one week). ]An adapted outcome measure to assess state self-compassion, defined as self-compassion that can change in the moment.
- Perfectionistic cognitions Inventory [ Time Frame: Change from baseline perfectionistic cognitions through to study completion (anticipated one week). ]Outcome measure to assess automatic perfectionistic thoughts, defined as automatic thoughts to do with perfection. They are included in this study as potential moderator of the impact of the intervention on shame and self-compassion.
- Pediatric Inventory for Parents [ Time Frame: Change from baseline parental stress through to study completion (anticipated one week). ]Outcome measure to assess parental stress
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03504605
|Sheffield Childrens Hospital|
|Sheffield, United Kingdom|
|Principal Investigator:||Catherine Lilley||University of Sheffield|
|Study Director:||Georgina Rowse||University of Sheffield|
|Study Director:||Fuschia Sirois||University of Sheffield|
|Study Director:||Amrit Sinha||University of Sheffield|
|Principal Investigator:||Kirsteen Meheran||University of Sheffield|